Eplontersen Exceeds Established Thresholds for Symptom and Disability Improvement in ATTRv-PN
ATTRv-PN Treatment Vutrisiran Demonstrates Long-Term Efficacy in Open-Label HELIOS-A Extension
Defining Remyelination in the Context of Multiple Sclerosis
Once-Daily Oral Pill for Obstructive Sleep Apnea Shows Promising Phase 3 Results, Paving Way for FDA Submission